Cookies used for improved website experience

Siemens Healthineers and our partners use cookies and other similar technologies to operate the Siemens Healthineers websites and personalize content and ads. You may find out more about how we use cookies by clicking "Show details" or by referring to our Cookie Policy.
You may allow all cookies or select them individually. And you may change your consent and cookie preferences anytime by clicking on the "Review and change your consent" button on the Cookie Policy page.

Reducing the Risk of Non-target Prostatic Artery Embolization

1min
Published on March 24, 2018

Courtesy: Andre Uflacker, MD, and Ziv J. Haskal, MD, Department of Radiology and Medical Imaging, Division of Vascular and Interventional Radiology, University of Virginia, Charlottesville, VA, USA


The patient was a 72-year-old male with lower urinary tract symptoms caused by benign prostatic hyperplasia. Symptoms consisted of straining, hesitancy, and weak stream, with a frequency of almost every hour during the day, and 8 episodes of nocturia. Prostatomegaly was present with a total volume of 53 mL. Prior to treatment, the patient’s International Prostate Symptom Score (IPSS) was 22, with a peak urine flow rate of 4 mL/s. One year after treatment, his IPSS was 4, and peak flow rate was 6 mL/s. Nocturia improved to 3 episodes per night, down from 8. Straining, hesitancy, and weak stream were all improved to the patient’s satisfaction.

Download the full clinical case here

reducing-the-risk